1887

oa CSIR Science Scope - Picking up where pharmaceutical giants have left off : developing an artemisinin alternative : malaria

Volume 4, Issue 3
  • ISSN :

 

Abstract

In another research project, Dr Chris Parkinson and his team of synthetic chemists are pursuing a similar objective : a new malaria drug; fewer side effects; affordable; with reduced reliance on a single source. They have set their minds on developing an artemisinin-based derivative. This class of drugs, called peroxides, is the only class of drugs to which Plasmodium falciparum has not yet shown signs of resistance. Recent Cambodian studies, however, have shown a slowing down in the rate at which the artemisinins act - suggesting that true resistance may emerge in the near future.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/csir_sci/4/3/EJC29647
2009-11-01
2016-12-09

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error